Dr. Mohamed Erritouni, MD

Dr. Erritouni practices at Mohamed Erritouni MD Inc in Delray Beach, Florida.

Dr. Erritouni's NPI, 1396924734, was assigned on November 2, 2007. Dr. Erritouni graduated from Hassan II University Faculty of Medicine in 1984. Dr. Erritouni holds Florida license ME107904.

Dr. Erritouni's primary practice is Mohamed Erritouni MD Inc, at 5130 W Linton Blvd, Delray Beach, FL 33484 in Palm Beach County. The practice phone is (561) 495-9289.

Dr. Erritouni's primary practice is Mohamed Erritouni MD Inc in Delray Beach, Florida. Dr. Erritouni is also affiliated with Delray Medical Center. The medical group on file is Elena Yamaguchi MD, PA. Dmand AI also links Dr. Erritouni to 2 more hospitals, 2 group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Erritouni practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Erritouni's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Erritouni is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Erritouni's licenses on file in 2 states: Florida and New York.

Dmand AI lists acute sinusitis, acute skin infection, hiv/aids, joint or bone infection, pneumonia and UTI among the conditions Dr. Erritouni treats.

CMS data shows 1,224,359 Medicare services from Dr. Erritouni across 18 procedure codes in 2024, for 1,281 Medicare patients. Medicare paid $859,597 for them.

CMS counts 1,281 Medicare patients who saw Dr. Erritouni in 2024. The largest group is 85 and over, with 505 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Erritouni's median patient age at 73, with 49% women.

In 2024, Dr. Erritouni wrote 1,278 Medicare Part D claims for 470 patients. 84% of them were for generic drugs. CMS names the drug for 1,116 of them, across 25 drugs with 11 or more claims each, at $410,521 in total drug cost. In 2023, CMS named 940 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Erritouni for performance year 2024, reported individually. Dr. Erritouni accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Erritouni, published from 2011 to 2012. Dr. Erritouni's most frequent co-authors are Brian D. Johnston, MD, Nessrine Hussein Ktaich, MD and Jaime H. Nieto, MD.

CMS Open Payments shows 245 general payments to Dr. Erritouni from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 87% of the total. Cumberland Pharmaceuticals, Inc. paid the most, $31,295.

Dmand AI lists 1 award for Dr. Erritouni, most recently CMS Stage 1 EHR in 2013.

Dr. Erritouni graduated from Hassan II University Faculty of Medicine in 1984.

Dr. Erritouni is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.